Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism
Sung Hee Lim, Sook-young Woo, Seonwoo Kim, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim
Cancer Res Treat. 2016;48(1):312-321.   Published online 2015 Mar 2     DOI: https://doi.org/10.4143/crt.2014.266
Citations to this article as recorded by Crossref logo
Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features
Yingxia Lan, Jinqiu Guan, Jia Zhu, Juan Wang, Mengzhen Li, Chengtao Sun, Feifei Sun, Junting Huang, Suying Lu, Yizhuo Zhang
Leukemia Research.2021; 103: 106537.     CrossRef
Predicting the Incidence of Venous Thromboembolism Using the Khorana Score: A Literature Review
Akari Nishimura, Yoshiaki Ikeda
YAKUGAKU ZASSHI.2021; 141(4): 611.     CrossRef
The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma
Onur Kirkizlar, Tugcan Alp Kirkizlar, Elif Gulsum Umit, Ismail Asker, Mehmet Baysal, Volkan Bas, Sedanur Karaman Gulsaran, Ufuk Demirci, Ahmet Muzaffer Demir
Clinical Lymphoma Myeloma and Leukemia.2020; 20(8): 542.     CrossRef
Prediction of survival in non-Hodgkin lymphoma based on markers of systemic inflammation, anemia, hypercoagulability, dyslipidemia, and Eastern Cooperative Oncology Group performance status
Ivan Dzis, Oleksandra Tomashevska, Yevhen Dzis, Zoryana Korytko
Acta Haematologica Polonica.2020; 51(1): 34.     CrossRef
Mechanisms and biomarkers of cancer-associated thrombosis
Ann S. Kim, Alok A. Khorana, Keith R. McCrae
Translational Research.2020; 225: 33.     CrossRef
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
Stefan Hohaus, Francesca Bartolomei, Annarosa Cuccaro, Elena Maiolo, Eleonora Alma, Francesco D’Alò, Silvia Bellesi, Elena Rossi, Valerio De Stefano
Cancers.2020; 12(5): 1291.     CrossRef
Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis
Knut A. Mosevoll, Silje Johansen, Øystein Wendelbo, Ina Nepstad, Øystein Bruserud, Håkon Reikvam
Frontiers in Medicine.2018;[Epub]     CrossRef
Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice
Joanna Rupa-Matysek, Katarzyna Brzeźniakiewicz-Janus, Lidia Gil, Zbigniew Krasiński, Mieczysław Komarnicki
Cancer Medicine.2018; 7(7): 2868.     CrossRef
Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma
Joanna Rupa-Matysek, Lidia Gil, Marta Barańska, Dominik Dytfeld, Mieczysław Komarnicki
Oncotarget.2018; 9(30): 21190.     CrossRef
Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma
Joanna Rupa-Matysek, Lidia Gil, Renata Kroll-Balcerzak, Marta Barańska, Mieczysław Komarnicki
Hematological Oncology.2017; 35(4): 456.     CrossRef
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients
Patrizia Ferroni, Fabio Massimo Zanzotto, Noemi Scarpato, Silvia Riondino, Umberto Nanni, Mario Roselli, Fiorella Guadagni
Medical Decision Making.2017; 37(2): 234.     CrossRef
Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma
Ina Hornemann Borg, Mette Dahl Bendtsen, Martin Bøgsted, Jakob Madsen, Marianne Tang Severinsen
Leukemia & Lymphoma.2016; 57(12): 2771.     CrossRef
Risk of thromboembolism with lymphoma: myth or reality?
Kate L. Burbury, Marliese Alexander, David A. Westerman
Leukemia & Lymphoma.2016; 57(12): 2736.     CrossRef